108122-24-3 Usage
Uses
Used in Pharmaceutical Industry:
2(1H)-Pyridinone,6-(1-piperazinyl)-(9CI) is utilized as a prospective active pharmaceutical ingredient for the development of new drugs targeting neurological disorders. Its interaction with various central nervous system receptors makes it a candidate for treating such conditions.
Used in Anticancer Research:
In the field of oncology, 2(1H)-Pyridinone,6-(1-piperazinyl)-(9CI) is studied for its potential as an anticancer agent, given its ability to affect cellular processes that may be pivotal in controlling or preventing the proliferation of cancer cells.
Used in Chemical Synthesis:
2(1H)-Pyridinone,6-(1-piperazinyl)-(9CI) serves as a ligand in the synthesis of metal complexes, which can have applications in various areas such as catalysis, material science, and as potential therapeutic agents.
Used in Research and Development:
2(1H)-Pyridinone,6-(1-piperazinyl)-(9CI) is also used as a subject of research and development in both academic and industrial laboratories, given its unique structure and potential to yield new insights and applications in the chemical and pharmaceutical realms.
Check Digit Verification of cas no
The CAS Registry Mumber 108122-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,1,2 and 2 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 108122-24:
(8*1)+(7*0)+(6*8)+(5*1)+(4*2)+(3*2)+(2*2)+(1*4)=83
83 % 10 = 3
So 108122-24-3 is a valid CAS Registry Number.
108122-24-3Relevant academic research and scientific papers
6-Alkoxy-N,N-disubstituted-2-pyridinamines as Anticonvulsant Agents
Pavia, Michael R.,Taylor, Charles P.,Hershenson, Fred M.,Lobbestael, Sandra J.
, p. 1210 - 1214 (2007/10/02)
The anticonvulsant effect of a series of 6-alkoxy-N,N-disubstituted-2-pyridinamines is described. An investigation was carried out to optimize the activity/side-effect ratio in this series of compounds. The most desirable profile was seen with 1-piperazine, 6, and this compound was selected for a more complete pharmacological evaluation. Overall, 6 has a pharmacological profile that is very similar to that of diphenylhydantoin (phenytoin). While nearly equipotent to phenytoin, animal studies suggest a fairly short duration of action. In addition, 6 exhibited some troublesome side effects including central nervous system depression and hypothermia.
